Adipose-derived resistin and gut-derived resistin-like molecule-β selectively impair insulin action on glucose production

Journal of Clinical Investigation

Volumn 111, Issue 2, 2003, Pages 225-230

  Rajala, Michael W ^a   Obici, Silvana ^a   Scherer, Philipp E ^a   Rossetti, Luciano ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; RECOMBINANT HORMONE; RESISTIN;

ADIPOSE TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HORMONE ACTION; HYPERINSULINEMIA; INSULIN RESISTANCE; LIVER; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN FAMILY; RAT;

EID: 0037241112     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI16521     Document Type: Article

References (30)

1. Steppan, C.M., et al. 2001. The hormone resistin links obesity to diabetes. Nature. 409:307-312.
2. Holcomb, I.N., et al. 2000. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J. 19:4046-4055.
3. Steppan, C.M., et al. 2001. A family of tissue-specific resistin-like molecules. Proc. Natl. Acad. Sci. USA. 98:502-506.
4. Rajala, M.W., et al. Cell type-specific expression and coregulation of murine resistin and resistin-like molecule-α in adipose tissue. Mol. Endocrinol. 16:1920-1930.
5. Yamauchi, T., et al. 2001. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7:941-946.
6. Fruebis, J., et al. 2001. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. USA. 98:2005-2010.
7. Berg, A.H., Combs, T.P., Du, X., Brownlee, M., and Scherer, P.E. 2001. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 7:947-952.
8. Combs, T.P., Berg, A.H., Obici, S., Scherer, P.E., and Rossetti, L. 2001. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J. Clin. Invest. 108:1875-1881. doi: 10.1172/JCI200114120.
9. Shimomura, I., Hammer, R.E., Ikemoto, S., Brown, M.S., and Goldstein, J.L. 1999. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature. 401:73-76.
10. Uysal, K.T., Wiesbrock, S.M., Marino, M.W., and Hotamisligil, G.S. 1997. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature. 389:610-614.
11. McGarry, J.D. 1992. What if Minkowski had been ageusic? An alternative angle on diabetes. Science. 258:766-770.
12. Kahn, B.B., and Flier, J.S. 2000. Obesity and insulin resistance. J. Clin. Invest. 106:473-481.
13. Olefsky, J.M., and Saltiel, A.R. 2000 PPAR gamma and the treatment of insulin resistance. Trends Endocrinol. Metab. 11:362-368.
14. Rossetti, L., Smith, D., Shulman, G.I., Papachristou, D., and DeFronzo, R.A. 1987. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J. Clin. Invest. 79:1510-1515.
15. Wang, J., Liu, R., Hawkins, M., Barzilai, N., and Rossetti, L. 1998. A nutrient sensing pathway regulates leptin gene expression in muscle and fat. Nature. 393:684-688.
16. Rossetti, L., and Giaccari, A. 1990. Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats. J. Clin. Invest. 85:1785-1792.
17. Rossetti, L., et al. 1993. Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes. J. Clin. Invest. 92:1126-1134.
18. Bjorntorp, P. 1991. Metabolic implications of body fat distribution. Diabetes Care 14:1132-1143.
19. Kissebah, A.H. 1991. Insulin resistance in visceral obesity. Int. J. Obes. 15:109-115.
20. Clore, J.N., Helm, S.T., and Blackard, W.G. 1995. Loss of hepatic autoregulation after carbohydrate overfeeding in normal man. J. Clin. Invest. 96:1967-1972.
21. Oakes, N.D., Cooney, G.J., Camilleri, S., Chisholm, D.J., and Kraegen, E.W. 1997. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes. 46:1768-1774.
22. Wang, J., Obici, S., Morgan, K., Barzilai, N., Feng, Z., and Rossetti, L. 2001. Overfeeding rapidly induces leptin and insulin resistance. Diabetes. 50:2786-2791.
23. Boden, G., Chen, X., Ruiz, J., White, J.V., Rossetti, L. 1994. Mechanisms of fatty acid-induced inhibition of glucose uptake. J. Clin. Invest. 93:2438-2446.
24. Bergman, R.N., et al. 2001. Central role of the adipocyte in the metabolic syndrome. J. Investig. Med. 49:119-126.
25. Sindelar, D.K., et al. 1997. The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog. Diabetes. 46:187-196.
26. DeFronzo, R.A., Ferrannini, E., Wahren, J., and Felig, P. 1978. Lack of gastrointestinal mediator of insulin action in maturity-onset diabetes. Lancet. 2:1077-1079.
27. Miyawaki, K., et al. 1999. Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. Proc. Natl. Acad. Sci. USA. 96:14843-14847.
28. Murata, M., et al. 2002. Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells. J. Biol. Chem. 277:5667-5674.
29. Tschop, M., Smiley, D.L., and Heiman, M.L. 2000. Ghrelin induces adiposity in rodents. Nature. 407:908-913.
30. McTerman, P.G., et al. 2002. Increased resistin gene and protein expression in human abdominal adipose tissue. J. Clin. Endocrinol. Metab. 87:2407-2413.